Beth Faiman, CNP, PhD

Beth Faiman, CNP, PhD

Cleveland Clinic

Latest Videos

Panel discussion on partnerships and outpatient strategies for bispecifics in multiple myeloma with Dr. S. Vincent Rajkumar, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Beth Faiman, and Dr. Rafael Fonseca.

Second Line and Beyond

07/10/2026

Ep 4. Community Perspective: Partnerships and Outpatient Strategies for Bispecifics in Multiple Myeloma 

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
OncUpdates episode 3 features Dr. S. Vincent Rajkumar discussing managing side effects of BCMA bispecifics and Talquetamab in myeloma treatment.

Second Line and Beyond

07/09/2026

Ep 3. Managing Side Effects BCMA Bispecifics and Talquetamab in Myeloma

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
OncUpdates Episode 2 features Dr. S. Vincent Rajkumar discussing bispecifics: MajesTEC-3, MajesTEC-9, and MonumenTAL-3 with expert panel.

Second Line and Beyond

07/08/2026

Ep 2. The Advent of Bispecifics: MajesTEC-3, MajesTEC-9, and MonumenTAL-3

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
Dr. S. Vincent Rajkumar and colleagues discuss a new algorithm for second-line treatment of multiple myeloma in a medical webinar.

Second Line and Beyond

07/07/2026

Ep 1. The New Algorithm for Second-Line Treatment of Multiple Myeloma

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
Group of medical professionals discussing evolving treatment landscape in second-line and beyond multiple myeloma, with cityscape background.

Second Line and Beyond

06/26/2026

Evolving Treatment Landscape in Second-Line and Beyond Multiple Myeloma

Beth Faiman, CNP, PhDRafael Fonseca, MDS. Vincent Rajkumar, MDRahul Gosain, MD, MBARohit Gosain, MD